Antifibrotic effect of TY501 on bleomycin-induced pulmonary fibrosis in rats and related mechanism
10.3969/j.issn.1001-1978.2015.02.013
- VernacularTitle:甘草次酸衍生物TY501抗肺纤维化作用及机制研究
- Author:
Yanyan GENG
;
Bing YU
;
Zhixing ZHOU
;
Qianqian HU
;
Weiren XU
;
Lida TANG
- Publication Type:Journal Article
- Keywords:
glycyrrhetic acid derivatives;
TY501;
IPF;
bleomycin;
TGF-β;
MMPs
- From:
Chinese Pharmacological Bulletin
2015;(2):210-215
- CountryChina
- Language:Chinese
-
Abstract:
Aim To investigate TY501′s role in bleo-mycin ( BLM )-induced pulmonary fibrosis in rats. Methods Forty rats were randomly divided into 5 groups, including the sham operation, BLM, PFD, TY501(high and low dose) groups. After administra-tion of BLM intratracheally, PFD and TY501 were giv-en in each group daily, according to the dosage de-signed during 21 days. Lung coefficient, PaO2 were tested before killing the rats. The contents of ALB, ALP, LDH, GSH, HYP were detected by regent kit respectively. PCⅢ and COL4 were determined by ELISA. Results ( 1 ) Some indicators of alveolitis in early stage of IPF: the contents of lung coefficient in three treatment groups were lower and PaO2 was higher than those in BLM group ( P<0. 05 ); compared with BLM group, the contents of ALB, ALP, LDH in the treatment groups reduced on 21 st day ( P<0. 05 );the expression of GSH in BLM group was increased for feedback regulation and higher than the treatment groups and the sham operation group (P<0. 05);(2) some indicators of pulmonary interstitial fibrosis in late stage of IPF:the expressions of HYP, PCⅢand COL4 were reduced after the treatment. There were signifi-cant differences compared with BLM group ( P <0. 05 ) . Conclusions TY501 is valuable for the ther-apy of IPF, the same as the positive drug pirfenidone. TY501 attenuates BLM-induced pulmonary fibrosis, which may be related to the affection of TGF-βpathway and inhibition of MMPs.
